Carla Goulart Peron Explores The Role of Technology and Collaboration in Global Stroke Action
Carla Goulart Peron, Chief Medical Officer at Philips, shared on LinkedIn:
”When I first met Sheila Cristina Ouriques Martins years ago while working together on a clinical trial in Brazil we shared a belief that stroke care could – and must – reach more people.
It is a pleasure to reconnect with her in the Global Stroke Action Coalition, and it was an honor to join her on Becker’s Healthcare latest podcast to reflect on how far we’ve come, and to discuss how technology and collaboration are helping make this vision a reality and transforming stroke care.
Highlights from our conversation included:
- The power of connection: With the support of AI and telehealth, expert care can now reach even the most remote areas where local resources are limited – expanding access to high-quality stroke care.
- Collaboration at scale: This is critical – by uniting industry, hospitals, governments, and non-profit organizations, we can integrate innovation into healthcare systems and reduce the global burden of stroke.
Thank you to Sheila for sharing such powerful perspectives.
Advancing stroke care is a shared mission – and by working together, we have the power to ensure that every person, no matter where they live, can access the best possible stroke care when it matters most.
Listen to our conversation.”
Stay updated with Hemostasis Today.
-
Feb 16, 2026, 06:21C. Michael Gibson: Favorable Safety Outcomes With Asundexian
-
Feb 16, 2026, 06:18Jecko Thachil: What Do Clinicians Mean by “Coagulopathy”?
-
Feb 16, 2026, 06:04Inside 2026 Highlights of ASH in the Mediterranean, Middle East, and North Africa with Dr. Heghine Khachatryan
-
Feb 15, 2026, 10:56Don’t Miss PNH: Clinical Practice From ISTH – Medscape
-
Feb 15, 2026, 10:52Awareness and Research on Factor V Deficiency Are Critical – EHC
-
Feb 15, 2026, 10:43Peter Zdziarski: Protecting Patient Data in the Rare Disease Community
-
Feb 15, 2026, 10:31Michiel Voet: The Price Tag of a Whole Blood Strategy
-
Feb 15, 2026, 10:26Sifat Jubaira: K₂-EDTA vs K₃-EDTA – Same Anticoagulant, Very Different Accuracy
-
Feb 15, 2026, 09:29Gevorg Tamamyan: Childhood Cancer is Curable. Inequity Is Not